What is the registration number for COPAXONE 40MG/ML (GLATIRAMER ACETATE INJECTION) THREE TIMES A WEEK RX ONLY?

COPAXONE 40MG/ML (GLATIRAMER ACETATE INJECTION) THREE TIMES A WEEK RX ONLY is registered under USPTO registration number 5533589.

COP

USPTO Trademark Record

REGISTERED

COPAXONE 40MG/ML (GLATIRAMER ACETATE INJECTION) THREE TIMES A WEEK RX ONLY

Q: Who owns the COPAXONE 40MG/ML (GLATIRAMER ACETATE INJECTION) THREE TIMES A WEEK RX ONLY trademark?

The COPAXONE 40MG/ML (GLATIRAMER ACETATE INJECTION) THREE TIMES A WEEK RX ONLY trademark is owned by Teva Pharmaceutical Industries Limited.

Q: What class is the COPAXONE 40MG/ML (GLATIRAMER ACETATE INJECTION) THREE TIMES A WEEK RX ONLY trademark registered in?

The COPAXONE 40MG/ML (GLATIRAMER ACETATE INJECTION) THREE TIMES A WEEK RX ONLY trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

Q: What is the serial number for COPAXONE 40MG/ML (GLATIRAMER ACETATE INJECTION) THREE TIMES A WEEK RX ONLY?

The USPTO serial number for COPAXONE 40MG/ML (GLATIRAMER ACETATE INJECTION) THREE TIMES A WEEK RX ONLY is 87646713.

SN 87646713·Reg 5533589·Filed Oct 16, 2017

Owner Teva Pharmaceutical Industries Limited

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

COPAXONE 40MG/ML (GLATIRAMER ACETATE INJECTION) THREE TIMES A WEEK RX ONLY (Serial No. 87646713), Registration No. 5533589, is a registered US trademark filed on Oct 16, 2017 by Teva Pharmaceutical Industries Limited. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Section 8/9 declaration window: August 07, 2028

Mark Intelligence

COPAXONE 40MG/ML (GLATIRAMER ACETATE INJECTION) THREE TIMES A WEEK RX ONLY (Reg. #5533589) is a registered US trademark that has been protecting its owner, Teva Pharmaceutical Industries Limited, since 2017. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Oct 16, 2017

SERIAL

87646713

REG#

5533589

REGISTERED

Aug 07, 2018

Owner

Applicant

Teva Pharmaceutical Industries Limited

Entity

Not Provided

Address

5 Basel Street, Science Based Industries Campus, Petach Tikva, 49131

Country

Attorney

NameLaurence Rickles

Law firm

Laurence Rickles TEVA PHARMACEUTICALS USA, INC.

Address

400 Interpace Parkway, Building A, Parsippany, NJ 07054, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateOct 16, 2017

Serial Number87646713

Registration No.5533589

Registration DateAug 07, 2018

Status DateOct 10, 2024

Published for OppositionMay 22, 2018

Next RenewalAugust 07, 2028

Mark TypeDesign with words

Status DescriptionLive and registered, Section 8 and 15 accepted

Filing Signals

FILED

2017

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

First use anywhere: Jan 28, 2014

First use in commerce: Jan 28, 2014

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

30 events

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Oct 10, 2024

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Oct 10, 2024

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Oct 10, 2024

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

TEAS SECTION 8 & 15 RECEIVED

Apr 11, 2024

TEAS SECTION 8 & 15 RECEIVED

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Aug 07, 2023

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REGISTERED-PRINCIPAL REGISTER

Aug 07, 2018

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

May 22, 2018

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 22, 2018

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 02, 2018

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Apr 18, 2018

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINERS AMENDMENT E-MAILED

Apr 18, 2018

EXAMINERS AMENDMENT E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 18, 2018

APPROVED FOR PUB - PRINCIPAL REGISTER

EXAMINER'S AMENDMENT ENTERED

Apr 18, 2018

EXAMINER'S AMENDMENT ENTERED

EXAMINERS AMENDMENT -WRITTEN

Apr 18, 2018

EXAMINERS AMENDMENT -WRITTEN

PREVIOUS ALLOWANCE COUNT WITHDRAWN

Apr 09, 2018

PREVIOUS ALLOWANCE COUNT WITHDRAWN

WITHDRAWN FROM PUB - OG REVIEW QUERY

Mar 20, 2018

WITHDRAWN FROM PUB - OG REVIEW QUERY

LAW OFFICE PUBLICATION REVIEW COMPLETED

Mar 06, 2018

LAW OFFICE PUBLICATION REVIEW COMPLETED

ASSIGNED TO LIE

Mar 05, 2018

ASSIGNED TO LIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 27, 2018

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 23, 2018

TEAS/EMAIL CORRESPONDENCE ENTERED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 23, 2018

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 23, 2018

TEAS RESPONSE TO OFFICE ACTION RECEIVED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Feb 23, 2018

TEAS CHANGE OF CORRESPONDENCE RECEIVED

NON-FINAL ACTION E-MAILED

Feb 01, 2018

NON-FINAL ACTION E-MAILED

NON-FINAL ACTION WRITTEN

Feb 01, 2018

NON-FINAL ACTION WRITTEN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 01, 2018

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Jan 25, 2018

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Oct 26, 2017

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 25, 2017

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Oct 19, 2017

NEW APPLICATION ENTERED

COPAXONE 40MG/ML (GLATIRAMER ACETATE INJECTION) THREE TIMES A WEEK RX ONLY

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Teva Pharmaceutical Industries Limited

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Laurence Rickles

Resources

Company